Table 1 Demographic and clinical data of the MS patients and controls
From: Serum levels of leptin and adiponectin in patients with multiple sclerosis
MS patients (N = 30) | Controls (N = 30) | Test of significance | P | |
|---|---|---|---|---|
Age (years): Mean ± SD | 31.03 ± 6.31 | 31.4 ± 7.5 | 0.36 | 0.71 |
Gender: N (%) | 0.08 | 0.78 | ||
Male | 9 (30%) | 10 (33.3%) | ||
Female | 21 (70%) | 20 (66.7%) | ||
BMI (kg/m2) Mean ± SD | 28.4 ± 7.2 | 26.7 ± 6.5 | 0.95 | 0.5 |
Serum leptin (pg/ml) Mean ± SD | 14,963.96 ± 10,917.97 | 6389.61 ± 3473.51 | 20.7 | < 0.001* |
Serum adiponectin (ng/ml) Mean ± SD | 4352 ± 1275 | 3995 ± 1088 | 1.17 | 0.24 |
MS types: N (%) | ||||
RRMS | 24 (80.0%) | NA | ||
SPMS | 3 (10%) | |||
PPMS | 3 (10%) | |||
Patients in relapse N (%) | 12 (40%) | NA | ||
Onset of disease (years): Mean ± SD | 27 ± 7.6 | NA | ||
Duration of disease (years) Mean ± SD | 3.7 ± 3.5 | NA | ||
Total relapse number Mean ± SD | 3.23 ± 1.63 | NA | ||
ARR: Mean ± SD | 1.08 ± 0.89 | NA | ||
EDSS: Mean ± SD | 2.17 ± 1.87 | NA | ||
MSSS: Mean ± SD | 3.84 ± 2.6 | NA | ||
PI: mean ± SD | 0.83 ± 0.9 | NA | ||